Tag : Neuromyelitis optica

Latest News

FDA approves drug for treatment of neuromyelitis optica spectrum disorder

Newsemia
The U.S. Food and Drug Administration has approved Enspryng (satralizumab-mwge) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults with a particular antibody...
Latest News

Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

Newsemia
The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder. Source link...
Neurology

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Newsemia
Alexion Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 PREVENT study of Soliris in patients with anti-aquaporin-4 auto antibody-positive neuromyelitis optica spectrum...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy